01 1Hemmo Pharmaceuticals Pvt. Ltd
02 1Piramal Pharma Limited
03 1PolyPeptide Laboratories (Sweden) AB
04 1Polypeptide Laboratories San Diego, LLC
01 1TERLIPRESSIN
02 3Terlipressin
01 1Switzerland
02 2U.S.A
03 1Blank
NDC Package Code : 41701-009
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10g/10g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-016
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (6g/6g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63586-0124
Start Marketing Date : 2019-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (4g/4g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58862-0179
Start Marketing Date : 2022-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Terlipressin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terlipressin, including repackagers and relabelers. The FDA regulates Terlipressin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terlipressin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Terlipressin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Terlipressin supplier is an individual or a company that provides Terlipressin active pharmaceutical ingredient (API) or Terlipressin finished formulations upon request. The Terlipressin suppliers may include Terlipressin API manufacturers, exporters, distributors and traders.
click here to find a list of Terlipressin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Terlipressin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Terlipressin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Terlipressin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Terlipressin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Terlipressin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Terlipressin suppliers with NDC on PharmaCompass.
We have 2 companies offering Terlipressin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
